Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference32 articles.
1. American Cancer Society. Cancer facts and figures; 2003.
2. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark;Skuladottir;J Clin Oncol,2003
3. Neoadjuvant and adjuvant therapy of non-small cell lung cancer;Rajdev;Surg Oncol,2002
4. Non-small cell lung cancer: role of surgery for stages I–III;Pearson;Chest,1999
5. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials;Hotta;J Clin Oncol,2004
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder;Cancers;2021-05-14
2. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation;Clinical Transplantation;2019-02-21
3. Prognostic value of urokinase plasminogen activator system in non‑small cell lung cancer: A systematic review and meta‑analysis;Molecular and Clinical Oncology;2017-11-03
4. Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results;Biomarkers in Medicine;2016-02
5. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2015-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3